For the first time Ziccum CEO Göran Conradsson presents the story of LaminarPace to investors and analysts at Stockholm’s prestigious Erik Penser Bank, Stockholm, March 15, 1200. But book early. Seats are limited.
On March 15 Ziccum CEO Göran Conradsson presents on the commercialization of LaminarPace over the coming Quarters, and its unique ability to spray dry fragile vaccines into stable, active dry powders.
Göran Conradsson will be joining Inhalation Sciences AB CEO Fredrik Sjövall at Erik Penser Bank, Apelbergsgatan 27, Stockholm. Fredrik Sjövall will present on ISAB’s plans & prospects for 2018.
To take part, or register a request, please email ISAB CEO Fredrik Sjövall at the address below by latest 12 March.
Mob: +46 (0)70 64 50875